Rockwell Medical (RMTI) Tops Q1 EPS by 1c, raises guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street rises after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts RMTI Hot Sheet
Price: $8.07 -0.25%
Revenue Growth %: +14.9%
Financial Fact:
Gross Profit: 1.58M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +14.9%
Financial Fact:
Gross Profit: 1.58M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
Rockwell Medical (NASDAQ: RMTI) reported Q1 EPS of ($0.02), $0.01 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $22.7 million versus the consensus estimate of $22.23 million.
GUIDANCE:
Rockwell Medical sees FY2024 revenue of $90-94 million, versus the consensus of $88.974 million.
For earnings history and earnings-related data on Rockwell Medical (RMTI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- MFA Financial (MFA) Misses Q3 EPS by 2c
- OPENLANE, Inc. (OPLN) Tops Q3 EPS by 5c, Beats on Revenue; Offers FY26 EPS Guidance
- Uber Q3 profit, revenue beat estimates as gross bookings jump 20%
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
